NACDS RxImpact day to keep DIR fee reform front-and-center
A record number of pharmacy advocates from all 50 states are expected to travel to Washington, D.C., to urge direct and indirect renumeration, or DIR fee reform at NACDS RxImpact Day on Capitol Hill, to be held March 5 to 6.
“This event will make a powerful statement to the Trump administration and to Congress about the crucial need for DIR fee reform," NACDS president and CEO Steve Anderson said.
Advocates, many in their white pharmacist coats, will make the case that this reform is necessary right now to reduce patients’ out-of-pocket drug costs, to reduce overall healthcare costs as a result of enhanced medication adherence, and to advance the viability of pharmacies by reversing an absolutely unsustainable reimbursement situation, Anderson said.
Anderson went on to say that more than half of all NACDS chain member companies will send representatives to NACDS RxImpact Day on Capitol Hill, which is "a new high."
"In addition, this year’s event will set a new high-water mark for companies participating for the first time. We will welcome nine new companies. The stage is set to send an unmistakable message that the Department of Health and Human Services was right to propose DIR fee reform in the “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses” proposed rule, and that it should be included in the final rule,” Anderson said.
A poll conducted by Morning Consult in January, and commissioned by NACDS found that 86% of registered voters support pharmacists using their expertise to build on 2018’s “gag-clause” prevention law and identify other ways to lower patients’ costs.
“This event will make a powerful statement to the Trump administration and to Congress about the crucial need for DIR fee reform," NACDS president and CEO Steve Anderson said.
Advocates, many in their white pharmacist coats, will make the case that this reform is necessary right now to reduce patients’ out-of-pocket drug costs, to reduce overall healthcare costs as a result of enhanced medication adherence, and to advance the viability of pharmacies by reversing an absolutely unsustainable reimbursement situation, Anderson said.
Anderson went on to say that more than half of all NACDS chain member companies will send representatives to NACDS RxImpact Day on Capitol Hill, which is "a new high."
"In addition, this year’s event will set a new high-water mark for companies participating for the first time. We will welcome nine new companies. The stage is set to send an unmistakable message that the Department of Health and Human Services was right to propose DIR fee reform in the “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses” proposed rule, and that it should be included in the final rule,” Anderson said.
A poll conducted by Morning Consult in January, and commissioned by NACDS found that 86% of registered voters support pharmacists using their expertise to build on 2018’s “gag-clause” prevention law and identify other ways to lower patients’ costs.